Molecular Inconsistencies in a Fragile X Male with Early Onset Ataxia

Yun Tae Hwang1,2, Tracy Dudding3,4, Solange Mabel Aliaga5,6,7

  • 1Department of Neurology, Gosford Hospital, Gosford 2250, Australia. y.hwang@ucl.ac.uk.

Genes
|September 23, 2016
PubMed

Insights

A fragile X syndrome patient with a full mutation FMR1 gene showed mosaicism for unmethylated alleles, explaining milder symptoms and ataxia. This highlights the importance of sensitive testing for fragile X associated tremor/ataxia syndrome.

Area of Science:

  • Genetics
  • Neurodegenerative Disorders
  • Molecular Biology

Background:

  • Fragile X syndrome (FXS) is caused by a full mutation (FM) in the FMR1 gene, typically leading to severe neurodevelopmental impairment.
  • Mosaicism for premutation (PM) or FM alleles, and unmethylated FM (UFM) alleles, are linked to milder FXS phenotypes and fragile X associated tremor/ataxia syndrome (FXTAS).

Observation:

  • A 38-year-old male diagnosed with FXS presented with a 100% methylated FM allele detected by Southern blot (SB), suggesting complete FMR1 gene silencing.
  • Despite the methylation pattern, his cognitive scores were less severe than typical FXS, and he exhibited tremor and ataxia.

Findings:

  • Sensitive PCR-based methylation testing revealed a 60-70% proportion of UFM alleles in blood, buccal, and saliva samples.
  • Real-time PCR confirmed incomplete FMR1 gene silencing, indicating the presence of UFM alleles missed by SB.

Implications:

  • The presence of UFM alleles, not detected by SB, likely explains the patient's milder FXS phenotype and ataxic gait, potentially related to FXTAS.
  • Further clinical and molecular monitoring is warranted, especially if symptoms progress, to fully understand the role of UFM alleles in this patient.